Literature DB >> 9027934

Adverse effect of treatment gaps in the outcome of radiotherapy for laryngeal cancer.

W Duncan1, R H MacDougall, G R Kerr, D Downing.   

Abstract

BACKGROUND AND
PURPOSE: A correlation has been demonstrated between unplanned prolongation of radiotherapy and increased local relapse. This review was performed to assess the importance of overall time on the outcome of curative radiotherapy of larynx cancer.
MATERIALS AND METHODS: Retrospective analysis was performed of 383 patients with laryngeal cancer managed by elective radiotherapy between 1976-1988 in the Department of Clinical Oncology, University of Edinburgh, Western General Hospital, Edinburgh All cancers were confirmed histologically to be squamous cell carcinomas. All subjects received radiotherapy in 20 daily fractions (except Saturdays and Sundays), employing individual beam direction techniques and computer dose distribution calculations. Main outcome measures were complete resolution of the cancer in the irradiated volume; local relapse; survival and cause-specific survival rates.
RESULTS: Radiotherapy was completed without any unplanned interruption (28 +/- 2 days) in 230/383 (60%) of patients. A statistically significant two-fold increase in local relapse rates was observed when treatment was given in 31 days or more. There also was a statistically significant four-fold increase in laryngeal cancer deaths when the treatment time exceeded 30 days.
CONCLUSIONS: In patients with laryngeal cancer, accelerated repopulation of cancer cells probably occurs after the start of radiotherapy. When the overall treatment time is 4 weeks or less, gaps at weekends are not detrimental. However, long holiday periods or gaps in treatment longer than 4 days increase the risk of laryngeal cancer relapse and cancer-related mortality. Significant gaps in treatment should be avoided. If treatment has to be prolonged, additional radiation dose should be prescribed to compensate for increased tumour cell proliferation.

Entities:  

Mesh:

Year:  1996        PMID: 9027934     DOI: 10.1016/s0167-8140(96)01838-5

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  17 in total

1.  Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays.

Authors:  M Maciá I Garau; J Solé Monné; M J Cambra Serés; C Monfà Binefa; M Peraire Llopis
Journal:  Clin Transl Oncol       Date:  2009-05       Impact factor: 3.405

2.  The "rocky treatment course": identifying a high-risk subgroup of head and neck cancer patients for supportive interventions.

Authors:  Horia Vulpe; Janet Ellis; Shao Hui Huang; Eshetu G Atenafu; Raymond W Jang; Gary Rodin; Jolie Ringash
Journal:  Support Care Cancer       Date:  2016-11-04       Impact factor: 3.603

Review 3.  Ionizing radiation: the good, the bad, and the ugly.

Authors:  Julie L Ryan
Journal:  J Invest Dermatol       Date:  2012-01-05       Impact factor: 8.551

Review 4.  Effectiveness of hyaluronic acid gel (Jalosome soothing gel) for the treatment of radiodermatitis in a patient receiving head and neck radiotherapy associated with cetuximab: A case report and review.

Authors:  Giovanni Presta; Andrea Puliatti; Loris Bonetti; Angela Tolotti; Davide Sari; Dario Valcarenghi
Journal:  Int Wound J       Date:  2019-09-02       Impact factor: 3.315

5.  Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximab.

Authors:  Shrujal S Baxi; Caitriona O'Neill; Eric J Sherman; Coral L Atoria; Nancy Y Lee; David G Pfister; Elena B Elkin
Journal:  Head Neck       Date:  2015-06-26       Impact factor: 3.147

Review 6.  [Delays and treatment interruptions: difficulties in administering radiotherapy in an ideal time-period].

Authors:  Carmen González San Segundo; Felipe A Calvo Manuel; Juan Antonio Santos Miranda
Journal:  Clin Transl Oncol       Date:  2005-03       Impact factor: 3.405

7.  Biologically effective dose and definitive radiation treatment for localized prostate cancer: treatment gaps do affect the risk of biochemical failure.

Authors:  P Sanpaolo; V Barbieri; D Genovesi
Journal:  Strahlenther Onkol       Date:  2014-03-04       Impact factor: 3.621

8.  Pentoxifylline and vitamin E reduce the severity of radiotherapy-induced oral mucositis and dysphagia in head and neck cancer patients: a randomized, controlled study.

Authors:  Rana Sayed; Lamia El Wakeel; Amr S Saad; Mohamed Kelany; Manal El-Hamamsy
Journal:  Med Oncol       Date:  2019-11-21       Impact factor: 3.064

9.  Adenosine A2A receptor plays an important role in radiation-induced dermal injury.

Authors:  Miguel Perez-Aso; Aránzazu Mediero; Yee Cheng Low; Jamie Levine; Bruce N Cronstein
Journal:  FASEB J       Date:  2015-09-28       Impact factor: 5.191

Review 10.  Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literature.

Authors:  José A González Ferreira; Javier Jaén Olasolo; Ignacio Azinovic; Branislav Jeremic
Journal:  Rep Pract Oncol Radiother       Date:  2015-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.